Back to News
Market Impact: 0.3
111, Inc. Posts Q2'26 Results As Asset-Light Shifts Lowers Revenue But Improved Efficiency; Stock Up
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany FundamentalsM&A & Restructuring
111, Inc. reported unaudited Q2 2026 results with revenue declining sharply versus the prior-year quarter. The decline reflects the China healthcare platform's ongoing strategic transition away from an asset-heavy operating model, creating near-term pressure on reported growth.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
YI-0.70
More News
- Binance seeks to shore up confidence after record $6.3 billion heist
- Ryanair CEO warns fares could rise by up to 20% in 2027 as fuel bill jumps by $2.2 billion
- The AI trade has broken down. How we got here and what investors should expect next
- Why is Alstom stock down 27% today?
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- Alstom shares sink 28% after outlook cut on Coradia Max execution issues